===============================================================================
PROTOCOL: Bronchoscopy Registry Study #2024-BR-0847
SUBJECT ID: S-047
DEMOGRAPHICS: 68 y.o. male, former smoker (40 pack-years, quit 2018)
DATE: 2024-10-15
OPERATOR: De-identified per protocol

PRIMARY INDICATION: Mediastinal lymph node staging
TARGET PATHOLOGY: Right lower lobe adenocarcinoma (biopsy-proven)

ANESTHESIA PROTOCOL:
└─ Agent: Midazolam IV
   ├─ Dose: 2mg initial, 1mg supplemental at T+15min
   └─ Total: 3mg
└─ Agent: Fentanyl IV
   ├─ Dose: 50mcg initial, 25mcg supplemental at T+20min
   └─ Total: 75mcg
└─ Sedation Level: Ramsay Scale maximum 3
└─ Monitoring Frequency: BP q5min, continuous SpO2

EBUS-TBNA STATIONS SAMPLED:
├─ Station 4R
│  ├─ Size: 10mm short-axis
│  ├─ Passes: 4
│  ├─ ROSE: Positive for malignant cells
│  └─ PET: Positive (SUV 6.2)
├─ Station 7
│  ├─ Size: 15mm short-axis
│  ├─ Passes: 4
│  ├─ ROSE: Positive for malignant cells
│  └─ PET: Positive (SUV 8.1)
└─ Station 10R
   ├─ Size: 7mm short-axis
   ├─ Passes: 3
   ├─ ROSE: Adequate, benign lymphocytes
   └─ PET: Negative

QUALITY METRICS:
├─ Systematic evaluation (N3→N2→N1): YES
├─ Photodocumentation all accessible stations: YES
├─ ROSE adequacy all sampled nodes: YES
├─ Molecular testing samples obtained: YES (from station 7)
└─ Protocol adherence: 100%

ADVERSE EVENTS:
└─ None (Grade 0)

DIAGNOSTIC YIELD: Pending final pathology (preliminary: N2 disease confirmed)

PATIENT IDENTIFIERS (SYNTHETIC):
Name: Robert Anderson | MRN: KK-9473-L | DOB: 05/19/1956
